It is quite well known that many older people with cancer, including of course, prostate cancer, will also have high cholesterol issues. And now it seems that Big Pharma, with its unscrupulous, money grabbing ways, is also ensuring that people with high cholesterol and taking Vytorin, will likely end up with cancer too. Thus ensuring Big Pharma can take two bites of the same apple, supplying drugs for both.

This is a ‘must read’ report from www.naturalnews.com and will once again emphasize the need for readers to be circumspect when considering prescription drug use. Don’t believe all that the drug manufacturer or regulators tell you.

(NaturalNews) In an unprecedented change of posture, the New England Journal of Medicine has reversed itself on the issue of whether Vytorin causes cancer. In the initial release of data back in July, NEJM stood by Merck and Schering-Plough, who hired an Oxford consultant to rule that a 50% statistically significant increased risk of cancer was by chance. I pointed out in an earlier posting that such statistical manipulation, based primarily on the opinion of the Oxford reviewer, was ridiculous. NEJM has had a sudden change of heart and now agrees with me.

See the full article at: http://www.naturalnews.com/024068.html

This entry was posted on Thursday, September 4th, 2008 at 1:56 pm and is filed under Informative Web-Sites, News Items. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.